Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGEN.VN | EPRX.TO | FRX.TO | ||
| Company | Nervgen Pharma Corp | Eupraxia Pharmaceuticals Inc | Fennec Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | TSX Venture | TSX | TSX | ||
| Open | 4.950 | 9.61 | 8.70 | ||
| High | 5.230 | 9.79 | 8.70 | ||
| Low | 4.930 | 9.38 | 8.70 | ||
| Latest | 5.150 | 9.44 | 8.70 | ||
| Change | +0.150 | -0.35 | +0.34 | ||
| % Change | +3.00% | -3.58% | +4.07% | ||
| Volume | 66,939 | 25,648 | 167 | ||
| 20-Day Average Volume | 49,920 | 91,074 | 856 | ||
| Previous Close | 5.000 | 9.79 | 8.36 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | TSX Biotechnology | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.554 | 10.43 | 10.79 | ||
| 20-Day Raw Stochastic | 23.73% | 3.83% | 10.50% | ||
| 20-Day Relative Strength | 42.10 | 39.26 | 38.20 | ||
| Weighted Alpha | +39.45 | +73.66 | -18.36 | ||
| Today's Opinion | 8% Buy | 24% Buy | 72% Sell | ||
| Previous Opinion | 24% Buy | 24% Buy | 72% Sell | ||
| Last Month's Opinion | 40% Buy | 80% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.20% since 03/09/26 | -10.10% since 03/19/26 | -16.02% since 03/19/26 | ||
| Low | 4.870 on 03/13/26 | 9.35 on 03/24/26 | 8.26 on 03/24/26 | ||
| High | 5.700 on 03/10/26 | 10.34 on 03/25/26 | 10.44 on 03/20/26 | ||
| 1-Month | |||||
| %Chg | -10.28% since 02/13/26 | -15.94% since 02/26/26 | -25.32% since 02/26/26 | ||
| Low | 4.870 on 03/13/26 | 9.35 on 03/24/26 | 8.26 on 03/24/26 | ||
| High | 6.050 on 02/23/26 | 11.70 on 03/02/26 | 11.79 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | -11.21% since 12/16/25 | -5.79% since 12/24/25 | -18.16% since 12/22/25 | ||
| Low | 4.870 on 03/13/26 | 9.35 on 03/24/26 | 8.26 on 03/24/26 | ||
| High | 8.490 on 01/08/26 | 12.86 on 01/21/26 | 12.45 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | +38.07% since 09/16/25 | +18.15% since 09/26/25 | -31.01% since 09/26/25 | ||
| Low | 3.200 on 11/06/25 | 7.35 on 11/07/25 | 8.26 on 03/24/26 | ||
| High | 8.490 on 01/08/26 | 12.86 on 01/21/26 | 13.83 on 10/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 407,944 | 602,116 | 285,603 | ||
| Shares Outstanding, K | 79,213 | 61,503 | 34,163 | ||
| Annual Sales | 0 | 0 | 47,538,000 | ||
| Annual Net Income | -24,005,895 | -38,576,143 | -436,000 | ||
| Last Quarter Sales | 0 | 0 | 12,462,000 | ||
| Last Quarter Net Income | -4,156,070 | -16,711,252 | -638,000 | ||
| 60-Month Beta | 0.54 | 1.49 | 3.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/24/25 | -0.37 | -0.17 on 03/24/26 | ||
| Latest Earnings Date | N/A | N/A | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||